I agree. The market probably will not care about this announcement, but I do. I have a lot of $ (at least for me) invested in this company, and the thought of the FDA letter throwing off our trials overseas was un-nerving. Any reassurance that we remain strongly on track, especially as validated buy a group like this is welcome news to me.